About Viruj Pharma
Viruj Pharma is a company based in Hyderabad (India). The company has 44 employees as of March 31, 2024. Viruj Pharma offers products and services including Fluconazole and Fexofenadine.
- Headquarter Hyderabad, India
- Employees 44 as on 31 Mar, 2024
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Viruj Pharmaceuticals Private Limited
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$5.92 M (USD)-46.78as on Mar 31, 2023
-
Net Profit
$149.49 K (USD)-71.98as on Mar 31, 2023
-
EBITDA
$239.97 K (USD)-81.96as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
44
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viruj Pharma
Viruj Pharma offers a comprehensive portfolio of products and services, including Fluconazole and Fexofenadine.
Fluconazole is produced as an active pharmaceutical ingredient for antifungal treatments.
Fexofenadine is manufactured as an active pharmaceutical ingredient for antihistamine applications.
Funding Insights of Viruj Pharma
Detailed funding history for Viruj Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Viruj Pharma
Investment portfolio details for Viruj Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Viruj Pharma
Detailed financials for Viruj Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Viruj Pharma Comparisons
Peer comparison for Viruj Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Viruj Pharma
Detailed competitors of Viruj Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Viruj Pharma
Complete news archive for Viruj Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viruj Pharma
Viruj Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2024, the latest employee count at Viruj Pharma is 44.
Annual revenue of Viruj Pharma is $5.92M as on Mar 31, 2023.
Viruj Pharma is identified as a key API manufacturer based in Hyderabad, India, where a wide range of active pharmaceutical ingredients is produced, including Fluconazole and Fexofenadine. Strict quality standards such as Schedule M and ICH Q7 are adhered to, with processes involving continuous and batch manufacturing. Safety and environmental regulations are complied with through regular training and efforts to minimize impacts. The company serves global markets by developing complex APIs for therapy advantages, focusing on scale-up and commercial production.
Viruj Pharma offers Fluconazole and Fexofenadine.